Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, proudly announced that Egypt has received official certification from the World Health Organization (WHO) for successfully controlling Hepatitis B, making Egypt the first country in the region to achieve this significant milestone. The announcement was made during his participation in the Cairo Declaration session on Breast Cancer, a collaborative effort between the WHO and the Presidential Initiative for Women’s Health.
Dr. Naima Abdel, WHO Representative in Egypt, confirmed in an exclusive statement to “Youm7” at the International Conference on Breast Cancer and Women’s Cancers that the Hepatitis B control certification has been officially granted by the WHO. The certificate will be formally announced once it is delivered to Egypt’s Ministry of Health and Population. Dr. Abdel highlighted Egypt’s impressive track record in eradicating several infectious diseases, including Hepatitis C, malaria, polio, and schistosomiasis, alongside its significant efforts in combating breast cancer through the Presidential Initiative for Women’s Health.
Additionally, Dr. Hisham El-Ghazaly, Professor of Oncology at Ain Shams University and Chairman of the National Committee for the Presidential Initiative for Women’s Health, introduced Professor Ahmed Ashour from Oxford University. Professor Ashour, Director of the Ovarian Cancer Cell Laboratory, presented groundbreaking research on the development of a new ovarian cancer vaccine using personalized medicine techniques. This innovative research holds the potential to revolutionize cancer treatment and reduce the need for preventative surgeries in genetically predisposed individuals. He also emphasized the success of preventive vaccines in reducing cervical cancer rates, suggesting that similar strategies could be applied to ovarian and lung cancers, particularly with early detection.
This achievement marks a critical milestone in Egypt’s ongoing efforts to improve public health and further solidifies the nation’s commitment to combating infectious diseases and advancing cancer research.
